Literature DB >> 32809963

Severe diabetic ketoacidosis and coronavirus disease 2019 (COVID-19) infection in a teenage patient with newly diagnosed diabetes.

Soghra Rabizadeh1, Minoosadat Hajmiri1, Armin Rajab1, Hamid Emadi Kouchak2, Manouchehr Nakhjavani1.   

Abstract

Objectives Recently, World Health Organization has declared coronavirus disease 2019 (COVID-19) infection a pandemic. Patients with diabetes may be at an increased risk of developing COVID-19 infection, as well as increased risk of morbidity and mortality. Although the current data have shown that the coronavirus infection generally has a milder course in children. Case presentation In this case report, we present a teenage patient with severe diabetic ketoacidosis (DKA) as the first manifestation of his diabetes and COVID-19 infection. Conclusions He was treated for DKA and COVID-19 infection, and fortunately, had a good response to the treatment.

Entities:  

Keywords:  COVID-19; diabetic ketoacidosis; newly diagnosed diabetes

Mesh:

Year:  2020        PMID: 32809963     DOI: 10.1515/jpem-2020-0296

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  8 in total

1.  Increased Severe Cases and New-Onset Type 1 Diabetes Among Children Presenting With Diabetic Ketoacidosis During First Year of COVID-19 Pandemic in Turkey.

Authors:  Eylem Kiral; Birgul Kirel; Merve Havan; Mehmet Keskin; Murat Karaoglan; Ahmet Yildirim; Murat Kangin; Mehmet Nur Talay; Tuba Urun; Umit Altug; Selman Kesici; Erennur Tufan; Ebru Kacmaz; Gurkan Bozan; Ebru Azapagasi; Mutlu Uysal Yazici; Zeynelabidin Ozturk; Osman Yesilbas; Gulay Karaguzel; Gulay Kaya; Ulkem Barlas; Muhterem Duyu; Merve Boyraz; Esra Sevketoglu; Nihal Akcay; Suna Hancili; Ayla Guven; Oǧuz Dursun; Nazan Ulgen Tekerek; Gokçen Ozcifci; Pinar Yazici; Eda Turanli; Tanil Kendirli; Fevzi Kahveci; Ayse Filiz Yetimakman; Agop Citak; Guntulu Şik; Ibrahim Bingol; Fatih Aygun; Cansu Durak; Resul Yilmaz; Fuat Bugrul; Yusuf Sari; Hakan Tekguç; Hatice Albayrak; Nazik Yener; Hasan Agin; Ekin Soydan; Dincer Yildizdas; Semine Ozdemir Dilek; Nilufer Yalindag; Feyza Incekoy-Girgin; Nuri Alacakir; Filiz Tutunculer; Mehmet Ozgur Arslanaoglu; Can Aydin; Muzaffer Bilgin; Enver Simsek; Ener Cagri Dinleyici
Journal:  Front Pediatr       Date:  2022-06-29       Impact factor: 3.569

Review 2.  Visceral Adipose Tissue: A New Target Organ in Virus-Induced Type 1 Diabetes.

Authors:  Danny Zipris
Journal:  Front Immunol       Date:  2021-08-04       Impact factor: 7.561

3.  Covid-19: A new cause of "provoked" A-β+ Ketosis-Prone Diabetes.

Authors:  Ruchi Gaba; Ashok Balasubramanyam
Journal:  J Diabetes Complications       Date:  2022-02-07       Impact factor: 2.852

4.  New-Onset Type 1 Diabetes in Children With SARS-CoV-2 Infection.

Authors:  Shashikanth Ambati; Maya Mihic; David Charles Rosario; Javier Sanchez; Adnan Bakar
Journal:  Cureus       Date:  2022-03-03

Review 5.  Prognosis of COVID-19 in the middle eastern population, knowns and unknowns.

Authors:  Iman Dandachi; Waleed Aljabr
Journal:  Front Microbiol       Date:  2022-08-31       Impact factor: 6.064

6.  Spike in Diabetic Ketoacidosis Rates in Pediatric Type 2 Diabetes During the COVID-19 Pandemic.

Authors:  Lily C Chao; Alaina P Vidmar; Senta Georgia
Journal:  Diabetes Care       Date:  2021-04-26       Impact factor: 19.112

7.  Type 1 diabetic manifestations in a young man triggered by COVID-19.

Authors:  Fatemeh Dehghani Firouzabadi; Mohammad Dehghani Firouzabadi; Fatemeh Moosaie; Saeedeh Rafiee; Alireza Esteghamati
Journal:  Clin Case Rep       Date:  2021-06-17

8.  Diabetic ketoacidosis in pediatric patients with type 1- and type 2 diabetes during the COVID-19 pandemic.

Authors:  Charlotte Loh; Paul Weihe; Nicole Kuplin; Kerstin Placzek; Susann Weihrauch-Blüher
Journal:  Metabolism       Date:  2021-07-30       Impact factor: 13.934

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.